MERTK and hepatocellular carcinoma: Moreover, further studies should be conducted to evaluate the impact of the MERTK rs4374383 SNP on liver fibrosis and the development of hepatocellular carcinoma after HCV elimination since patients with advanced fibrosis or cirrhosis are still at risk of disease progression [29].